Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals Limited has announced the application for quotation of 5,674,635 new ordinary fully paid securities on the ASX under the code TLX, dated April 11, 2024. This move indicates a growth phase for the company as they expand their presence in the pharmaceutical market.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
